Skip to main content
. Author manuscript; available in PMC: 2008 Jul 2.
Published in final edited form as: Drug Metab Dispos. 2007 Mar 7;35(6):973–980. doi: 10.1124/dmd.107.014779

Fig. 1.

Fig. 1

A, detection of CBR1 V88I by DNA sequence analysis. The chromatogram at the top shows the sequence trace from an individual with heterozygous (G/A) genotype. The chromatogram at the bottom shows the trace from a subject with homozygous (G/G) genotype. B, CBR1 V88I genotyping by real-time PCR. C, immunodetection of purified CBR1 V88 and CBR1 I88 with a specific anti-human CBR1 antibody.